Publication | Open Access
A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn Disease
19
Citations
9
References
2020
Year
Ustekinumab in refractory CD results in significant clinical and endoscopic improvement and reinduction may be a viable option to recapture response.
| Year | Citations | |
|---|---|---|
Page 1
Page 1